Biomolecules and Biomedicine

Scope & Guideline

Catalyzing Research for Global Health Solutions

Introduction

Welcome to your portal for understanding Biomolecules and Biomedicine, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2831-0896
PublisherASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO
Support Open AccessYes
CountryBosnia and Herzegovina
TypeJournal
Convergefrom 2023 to 2024
AbbreviationBIOMOL BIOMED / Biomol. Biomed.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIV SARAJEVO, MEDICAL FAC, CEKALUSA, SARAJEVO 90, BOSNIA & HERCEG

Aims and Scopes

The journal "Biomolecules and Biomedicine" is dedicated to advancing the understanding of biomolecular interactions and their implications in various biomedical fields. It encompasses a wide range of studies that explore molecular mechanisms, therapeutic strategies, and innovative technologies that can enhance health outcomes.
  1. Molecular Mechanisms in Disease:
    The journal emphasizes research focused on understanding the molecular underpinnings of diseases, including cancer, cardiovascular disorders, and metabolic diseases, through various experimental and computational approaches.
  2. Innovative Therapeutic Strategies:
    It covers studies that investigate novel therapeutic agents and strategies, including drug development, gene therapy, and targeted therapies, aimed at improving patient outcomes and addressing unmet medical needs.
  3. Biomaterials and Tissue Engineering:
    Research involving the development and application of biomaterials for medical purposes, including tissue engineering and regenerative medicine, is a core focus area.
  4. Clinical and Translational Research:
    The journal promotes studies that bridge laboratory findings with clinical applications, facilitating the translation of basic research into practical healthcare solutions.
  5. Technological Advances in Biomedical Research:
    It highlights the use of cutting-edge technologies such as artificial intelligence, machine learning, and bioinformatics in biomedical research, enhancing the understanding of complex biological systems.
  6. Epidemiology and Public Health:
    The journal addresses studies that explore epidemiological trends and public health implications of various diseases, contributing to the broader understanding of health determinants.
In recent years, "Biomolecules and Biomedicine" has witnessed the emergence of several trending themes that reflect the current priorities and innovations in biomedical research. These themes highlight the journal's responsiveness to evolving scientific inquiries and societal health challenges.
  1. Artificial Intelligence and Machine Learning:
    An increasing number of studies are utilizing AI and machine learning to analyze complex biological data, predict outcomes, and improve diagnostic accuracy, reflecting the growing trend of integrating computational tools in biomedical research.
  2. Personalized and Precision Medicine:
    There is a notable emphasis on research that tailors medical treatment to individual characteristics, including genetic and molecular profiling, aiming to enhance the efficacy of therapies across diverse patient populations.
  3. Immunotherapy and Cancer Research:
    The journal is seeing a surge in publications related to immunotherapy, specifically the development of novel immunotherapeutic agents and strategies to enhance the immune response against various cancers.
  4. Microbiome Studies:
    Research focusing on the human microbiome and its influence on health and disease is gaining traction, highlighting the importance of microbiota in various physiological and pathological processes.
  5. Regenerative Medicine and Stem Cell Research:
    There is an increased interest in regenerative medicine, particularly studies exploring stem cell applications for tissue repair and regeneration, which align with the journal’s focus on innovative therapeutic strategies.
  6. Environmental and Public Health Impacts:
    Emerging themes related to the impact of environmental factors on health, especially in the context of global health crises like the COVID-19 pandemic, are becoming more prominent in the journal's publications.

Declining or Waning

While "Biomolecules and Biomedicine" continues to evolve, certain themes have shown a declining trend in recent publications. This shift may reflect changes in research focus or emerging priorities in the biomedical field.
  1. Traditional Pharmacology Approaches:
    Research that primarily focuses on traditional pharmacological methods without integration of molecular biology or personalized medicine is becoming less frequent, as the field shifts towards more targeted and individualized therapeutic strategies.
  2. Basic Laboratory Techniques:
    Studies relying solely on basic laboratory techniques without the incorporation of advanced technologies like high-throughput screening or omics approaches are declining, as the field moves towards more sophisticated methodologies.
  3. Generalized Epidemiological Studies:
    While epidemiological research remains important, there is a noticeable decline in studies that do not leverage advanced statistical modeling or machine learning techniques, which are becoming standard in contemporary research.
  4. Non-Translational Research:
    There is a waning interest in purely basic science studies that do not demonstrate a clear pathway to clinical application or relevance, as the journal emphasizes translational research that connects laboratory findings with clinical outcomes.

Similar Journals

Progress in Biomedical Engineering

Empowering research that shapes the future of healthcare.
Publisher: IOP Publishing LtdISSN: Frequency:

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

ARCHIVES OF MEDICAL RESEARCH

Elevating clinical practices through impactful research.
Publisher: ELSEVIER SCIENCE INCISSN: 0188-4409Frequency: 8 issues/year

Archives of Medical Research is a prestigious scholarly journal dedicated to advancing the field of medicine through the dissemination of high-quality research findings. Published by Elsevier Science Inc., this esteemed journal has garnered significant recognition, boasting a remarkable impact factor and ranking in the top quartile (Q1) of its category, specifically in General Medicine with a Scopus rank of #30 out of 636 journals, placing it in the 95th percentile. Since its inception in 1992, Archives of Medical Research has served as a critical platform for researchers and professionals to share innovative insights and empirical studies that address pressing medical issues and enhance clinical practices. The journal welcomes a range of submissions, ensuring a diverse array of topics that reflect the latest trends and developments in medicine. As the journal continues to push the boundaries of medical research until at least 2025, it remains an essential resource for students, academics, and healthcare professionals striving to make a meaningful impact in the medical community.

BIOMEDICAL RESEARCH-TOKYO

Fostering Collaboration in Cutting-edge Biomedical Research
Publisher: BIOMEDICAL RESEARCH PRESS LTDISSN: 0388-6107Frequency: 6 issues/year

BIOMEDICAL RESEARCH-TOKYO is an esteemed interdisciplinary journal published by BIOMEDICAL RESEARCH PRESS LTD, dedicated to disseminating pioneering research and advancements in the fields of biochemistry, genetics, and medicine. Since its inception in 1980, the journal has established itself as a reputable source of knowledge, contributing significantly to the global scientific community with its strong emphasis on innovative findings and methodologies. With a consistent presence in the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it continues to attract a diverse range of research articles. While the journal does not operate as an open access platform, it remains an essential resource for researchers, professionals, and students seeking to further their understanding of biomedical sciences. Located in Sapporo, Japan, this journal fosters collaboration and knowledge sharing among the international biomedical research community, engaging readers through its compelling studies that span from 1980 to 2024.

Organogenesis

Pioneering Research in Embryology and Beyond.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Advancing the Frontiers of Biological and Medical Research
Publisher: SPRINGERISSN: 0007-4888Frequency: 12 issues/year

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Exploring the Foundations of Health and Disease
Publisher: ELSEVIERISSN: 0925-4439Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

BMC Molecular and Cell Biology

Unleashing innovative research in molecular and cell biology.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Journal of Biomedical Research

Pioneering Insights in Biochemistry, Genetics, and Molecular Biology
Publisher: NANJING MEDICAL UNIVISSN: 1674-8301Frequency: 6 issues/year

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.

Biophysics Reviews

Bridging the Gap Between Theory and Application in Biophysics
Publisher: AIP PublishingISSN: 2688-4089Frequency: 4 issues/year

Biophysics Reviews, published by AIP Publishing, is an emerging journal in the field of biophysics, aiming to bridge the gap between fundamental biophysical research and applied sciences. With an ISSN of 2688-4089, this journal provides a critical platform for the dissemination of high-quality reviews covering the interplay between biochemistry, molecular biology, biotechnology, and materials science. As of 2023, it provides essential insights for researchers and professionals interested in understanding biomolecular processes at a physical level. Although the journal is not currently open access, it is making strides in establishing its impact in the competitive landscape, as indicated by its Scopus rankings in various related fields, including biochemistry and bioengineering. With a focus on enhancing collaborations among scientists and practitioners, Biophysics Reviews is poised to become a vital resource for anyone looking to deepen their understanding of how biophysical principles can be applied to solve complex biological challenges.

Biomed Research International

Advancing biomedical knowledge, one discovery at a time.
Publisher: HINDAWI LTDISSN: 2314-6133Frequency: 1 issue/year

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.